Will o' the wisp: CCN4 as a novel molecular target in osteoarthritis.
about
Polymorphic variation of hypoxia inducible factor-1 A (HIF1A) gene might contribute to the development of knee osteoarthritis: a pilot study.CCN4 induces IL-6 production through αvβ5 receptor, PI3K, Akt, and NF-κB singling pathway in human synovial fibroblasts.Effect of ginger powder supplementation on nitric oxide and C-reactive protein in elderly knee osteoarthritis patients: A 12-week double-blind randomized placebo-controlled clinical trial.WISP-1 overexpression upregulates cell proliferation in human salivary gland carcinomas via regulating MMP-2 expression.Effect of Ginger Supplementation on Proinflammatory Cytokines in Older Patients with Osteoarthritis: Outcomes of a Randomized Controlled Clinical Trial.
P2860
Will o' the wisp: CCN4 as a novel molecular target in osteoarthritis.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Will o' the wisp: CCN4 as a novel molecular target in osteoarthritis.
@en
type
label
Will o' the wisp: CCN4 as a novel molecular target in osteoarthritis.
@en
prefLabel
Will o' the wisp: CCN4 as a novel molecular target in osteoarthritis.
@en
P2860
P1476
Will o' the wisp: CCN4 as a novel molecular target in osteoarthritis.
@en
P2093
Andrew Leask
P2860
P2888
P356
10.1007/S12079-010-0110-2
P577
2010-12-01T00:00:00Z